Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment

Currently, treating coronavirus disease 2019 (COVID-19) patients, particularly those afflicted with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exists. Severe pneumonia is recognized as a clinical syndrome charact...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Syed Shadab, Khan, Mohsin Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362822/
https://www.ncbi.nlm.nih.gov/pubmed/35880307
http://dx.doi.org/10.1016/j.jcyt.2020.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362822/
https://www.ncbi.nlm.nih.gov/pubmed/35880307
http://dx.doi.org/10.1016/j.jcyt.2020.07.002

Ejemplares similares